Stay updated on HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.

Latest updates to the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry: Revision: v3.4.2. The removed notice and prior revision (v3.4.1) related to government funding status and site operations, not to the trial record content.SummaryDifference0.3%

- Check21 days agoChange DetectedNotice about lapse in government funding added; Revision: v3.4.1 replacing previous revision v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedAdds a glossary toggle and green/red color-coded highlights for additions and deletions in the record history, and updates the revision note to v3.4.0.SummaryDifference0.4%

- Check42 days agoChange DetectedOn 2026-01-12, the History page adds Contacts/Locations and Study Status sections and records Revision: v3.3.4. The previous Revision: v3.3.3 from 2025-12-02 is removed.SummaryDifference0.3%

- Check64 days agoChange DetectedFooter updates show Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check78 days agoChange DetectedThe study status was updated to Completed on 2025-12-02. The Recruitment Status now shows Completed, replacing the previous Active, not recruiting entry.SummaryDifference0.3%

Stay in the know with updates to HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.